IndraLab

Statements


USP2 activates acute respiratory syndrome coronavirus papain-like protease. 1 / 1
| 1

eidos
"Meanwhile , drug specificity should be taken into consideration , because many chemical inhibitors have unexpected molecular targets [ 159 ] ; for example , a recent paper reported that a USP2 blocker also inhibits severe acute respiratory syndrome coronavirus 2 papain-like protease [ 160 ] ."